In:
The Laryngoscope, Wiley, Vol. 112, No. 2 ( 2002-02), p. 238-242
Abstract:
Objectives Cyclooxygenases (COX) are enzymes that catalyze the conversion of arachidonic acid to prostaglandins. COX‐2, unlike the constitutively expressed COX‐1, is an inducible enzyme upregulated during cell proliferation and inflammation. More recently, COX‐2 has been implicated in the development of numerous types of epithelial cancers. In addition, COX‐2 is highly expressed in several inflammatory diseases. Because of its dual role in inflammation and cancer, we were interested in determining if COX‐2 plays a role in the development of human thyroid carcinoma and Hashimoto's thyroiditis, an autoimmune condition frequently associated with thyroid malignancy. Materials and Methods Twenty paraffin‐embedded human tissue specimens, including normal, inflammatory, and neoplastic thyroid sections, were analyzed by immunohistochemical staining for expression of human COX‐2. In addition, COX‐2 protein expression was verified by Western blot in two specimens. Results Immunohistochemical staining confirmed the presence of COX‐2 in thyroid epithelial neoplasms, including papillary and follicular carcinomas. Moreover, COX‐2 expression was observed in patients with Hashimoto's thyroiditis. COX‐2 expression, however, was not observed in normal thyroid tissue, multinodular goiter, or anaplastic carcinoma. Conclusions We have shown that cyclooxygenase‐2 is expressed in thyroid carcinoma and thyroid epithelium from patients with Hashimoto's thyroiditis but not in normal thyroid. The expression of COX‐2 in both of these thyroid pathologies may provide a basis for the relationship between carcinogenesis and autoimmunity.
Type of Medium:
Online Resource
ISSN:
0023-852X
,
1531-4995
DOI:
10.1097/00005537-200202000-00008
Language:
English
Publisher:
Wiley
Publication Date:
2002
detail.hit.zdb_id:
2026089-1
detail.hit.zdb_id:
80180-X
Permalink